Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results.
Levy G, Schmidli H, Punch J, Tuttle-Newhall E, Mayer D, Neuhaus P, Samuel D, Nashan B, Klempnauer J, Langnas A, Calmus Y, Rogiers X, Abecassis M, Freeman R, Sloof M, Roberts J, Fischer L.
Levy G, et al.
Liver Transpl. 2006 Nov;12(11):1640-8. doi: 10.1002/lt.20707.
Liver Transpl. 2006.
PMID: 16598777
Free article.
Clinical Trial.